Company Filing History:
Years Active: 2013-2023
Title: Weiyong Li: Innovator in Drug Delivery and Multivariate Analysis
Introduction
Weiyong Li is a notable inventor based in Doylestown, PA (US). He has made significant contributions to the fields of drug delivery systems and quantitative analysis methods. With a total of 2 patents, his work showcases innovative solutions to complex problems.
Latest Patents
One of Weiyong Li's latest patents is a transdermal drug delivery system designed to alleviate acute and chronic musculoskeletal pain. This system features a backing layer, an adhesive layer, a topical applicator, a suitable quantity of drug, and a topical carrier. The topical applicator is securely connected to the backing layer by the adhesive layer. The drug and topical carrier are homogenously mixed to create a topical medication, which is retained and dispensed from the applicator. The applicator includes a flat body, blunted spikes to enhance surface area, and a containment rim to confine the medication effectively.
Another significant patent is the method for supervised principal component analysis (SPCA). This multivariate modeling method allows for quantitative analysis without the need for testing calibration samples using a reference method. The process involves designing calibration samples, producing a calibration data matrix, decomposing the matrix using PCA, and generating a prediction matrix for unknown samples. This method is particularly advantageous due to its high tolerance for variations in sample composition and manufacturing conditions.
Career Highlights
Throughout his career, Weiyong Li has worked with various companies, contributing his expertise to advance innovative technologies. His experience in the field has positioned him as a valuable asset in the development of new methodologies and systems.
Collaborations
Weiyong Li has collaborated with Chi Luo, enhancing the scope and impact of his inventions. Their partnership has fostered a creative environment for innovation and problem-solving.
Conclusion
Weiyong Li's contributions to drug delivery systems and quantitative analysis exemplify the spirit of innovation. His patents reflect a commitment to improving healthcare solutions and advancing scientific methodologies.